Daniel J. Duarte

Daniel J. Duarte

Auto-generated profile, based on publicly available information

Daniel J. Duarte

KWR Water Research Institute, Nieuwegein, the Netherlands

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Science of The Total Environment
Verified
Journal Article
Closed access
DDDaniel J. Duarte
Daniel J. Duarte
RORik Oldenkamp
Rik Oldenkamp
ARAd M.J. Ragas
Ad M.J. Ragas

5 April 2021 in Environmental Toxicology and Chemistry
Verified
Journal Article
Open access
PDF file
DDDaniel J. Duarte
Daniel J. Duarte
GNGunnar Niebaum
Gunnar Niebaum
VLVolker Lämmchen
Volker Lämmchen
EHEri van Heijnsbergen
Eri van Heijnsbergen
RORik Oldenkamp
Rik Oldenkamp
JKJörg Klasmeier
Jörg Klasmeier
Millions of people rely on active pharmaceutical ingredients (APIs) to prevent and cure a wide variety of illnesses in humans and animals, which has led to a steadily increasing consumption of APIs across the globe and concurrent releases of APIs into the environment. In the environment, APIs can have a detrimental impact on wildlife, particularly aquatic wildlife. Therefore, it is essential to assess their potential adverse effects to aquatic ecosystems. The European Water Framework Directive sets out that risk assessment should be performed at the catchment level, crossing borders where needed. The present study defines ecological risk profiles for surface water concentrations of 8 APIs (carbamazepine, ciprofloxacin, cyclophosphamide, diclofenac, erythromycin, 17α-ethinylestradiol, metformin, and metoprolol) in the Vecht River, a transboundary river that crosses several German and Dutch regions. Ultimately, 3 main goals were achieved: 1) the geo-referenced estimation of API concentrations in surface water using the geography-referenced regional exposure assessment tool for European rivers; 2) the derivation of new predicted-no-effect concentrations for 7 of the studied APIs, of which 3 were lower than previously derived values; and 3) the creation of detailed spatially explicit ecological risk profiles of APIs under 2 distinct water flow scenarios. Under average flow conditions, carbamazepine, diclofenac, and 17α-ethinylestradiol were systematically estimated to surpass safe ecological concentration thresholds in at least 68% of the catchment's water volume. This increases to 98% under dry summer conditions. Environ Toxicol Chem 2022;41:648–662. © 2021 The Authors. Environmental Toxicology and Chemistry published by Wiley Periodicals LLC on behalf of SETAC Abstract Spatially explicit environmental pharmaceutical risk profiles in the Vecht River basin under 2 climate condition scenarios.

11 July 2014 in Ecotoxicology
Verified
Journal Article
Closed access
PDF file
Amaia IrizarAmaia Irizar
Amaia Irizar
DDDaniel Duarte
Daniel Duarte
Lucia GuilherminoLucia Guilhermino
Lucia Guilhermino
IMIonan Marigómez
Ionan Marigómez
MSManu Soto
Manu Soto

28 February 2022 in Integrated Environmental Assessment and Management
Verified
Journal Article
Open access
PDF file
DDDaniel J. Duarte
Daniel J. Duarte
RORik Oldenkamp
Rik Oldenkamp
ARAd M. J. Ragas
Ad M. J. Ragas
Active pharmaceutical ingredients (APIs) can reach surface waters used for drinking water extraction and recreational activities, such as swimming and fishing. The aim of the present study was to systematically assess the lifetime human health risks posed by 15 individual APIs and their mixtures occurring in the German–Dutch transboundary Vecht River. An exposure model was developed and used to assess the combined risks of oral and dermal exposure under a variety of exposure conditions. A total of 4500 API uptake values and 165 lifetime risk values were estimated for 15 and 11 APIs, respectively. Overall, the lifetime human health risks posed by the APIs and their mixtures based on modeling results were deemed acceptable under typical exposure conditions. Under very extreme environmental conditions and human behavior, API mixture risks were of potential concern while the risks of individual APIs were negligible, with a few exceptions. The antibiotic doxycycline and analgesic phenazone showed the highest and lowest risks, respectively. The study did not evaluate the potential risks caused by metabolite compounds. Recommendations for water managers are provided to help improve the accuracy and utility of human health risk assessments of pharmaceuticals. Integr Environ Assess Manag 2022;18:1639–1654. © 2022 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals LLC on behalf of Society of Environmental Toxicology & Chemistry (SETAC). KEY POINTS Human health risks from direct toxicity associated with the lifetime exposure to pharmaceutical residues in the Vecht's River catchment were predominantly below safe limits. Doxycycline and diclofenac pose the highest risk yet are below the risk threshold under normal environmental conditions for most individuals. Human features and behavior combined with environmental conditions of varied complexity can be integrated into a relatively simple deterministic exposure model to estimate lifetime health risks of pharmaceuticals in the water environment. Local, regional, and national authorities can readily gain insight into the potential human health risks based on minimal information, bypassing unnecessary and laborious risk assessment.

3 July 2024 in Water Research X
Verified
Journal Article
Open access
DDDaniel J. Duarte
Daniel J. Duarte
RHRenske P.J. Hoondert
Renske P.J. Hoondert
EAElvio D. Amato
Elvio D. Amato
Milou M.L. DingemansMilou M.L. Dingemans
Milou M.L. Dingemans
SKStefan A.E. Kools
Stefan A.E. Kools
Xanthates, derivatives of xanthic acid, are widely utilized across industries such as agrochemicals, rubber processing, pharmaceuticals, metallurgical, paper and mining to help separate metals from ore. Despite their prevalent use, many registered xanthates lack comprehensive information on potential risks to human health and the environment. The mining sector, a significant consumer of xanthates, drives demand. However, emissions into the environment remain poorly understood, especially concerning water quality. A recent EU parliamentary voting on water legislation highlights the urgency to address water pollution and the potential toxicity of xanthates. While limited data exist on xanthate presence in the environment, existing studies indicate their toxicity and contribution to environmental pollution, primarily due to carbon disulfide, a decomposition product. Concerns are mounting over the release of xanthates and carbon disulfide, particularly in mining areas near populated regions and river tributaries, raising questions about downstream impacts and public health risks. Proposed expansions of xanthate-reliant mining activities in Europe, heighten concerns about emissions and water quality impacts. Current databases lack xanthate-related monitoring data, hindering environmental and health risk assessments. Addressing this gap requires water sampling and chemical analysis and investigations into the use, occurrence, and potential impacts of xanthates from industrial activities on water bodies, including those used for drinking water production is imperative.